For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

A method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who ...

A new study conducted by researchers from the Washington University School of Medicine identified an experimental drug that ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains of people destined to develop Alzheimer’s dementia can ...

For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...

Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.